Form 8-K - Current report:
SEC Accession No. 0001140361-24-028944
Filing Date
2024-06-05
Accepted
2024-06-05 08:00:49
Documents
51
Period of Report
2024-06-05
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ef20030639_8k.htm   iXBRL 8-K 27963
2 EXHIBIT 99.1 ef20030639_ex99-1.htm EX-99.1 88265
6 ef20030639_ex99-1slide1.jpg GRAPHIC 215771
7 ef20030639_ex99-1slide2.jpg GRAPHIC 568057
8 ef20030639_ex99-1slide3.jpg GRAPHIC 315490
9 ef20030639_ex99-1slide4.jpg GRAPHIC 288599
10 ef20030639_ex99-1slide5.jpg GRAPHIC 245418
11 ef20030639_ex99-1slide6.jpg GRAPHIC 151028
12 ef20030639_ex99-1slide7.jpg GRAPHIC 213993
13 ef20030639_ex99-1slide8.jpg GRAPHIC 296923
14 ef20030639_ex99-1slide9.jpg GRAPHIC 156410
15 ef20030639_ex99-1slide10.jpg GRAPHIC 339627
16 ef20030639_ex99-1slide11.jpg GRAPHIC 319350
17 ef20030639_ex99-1slide12.jpg GRAPHIC 258513
18 ef20030639_ex99-1slide13.jpg GRAPHIC 291869
19 ef20030639_ex99-1slide14.jpg GRAPHIC 304956
20 ef20030639_ex99-1slide15.jpg GRAPHIC 152100
21 ef20030639_ex99-1slide16.jpg GRAPHIC 363362
22 ef20030639_ex99-1slide17.jpg GRAPHIC 364466
23 ef20030639_ex99-1slide18.jpg GRAPHIC 313163
24 ef20030639_ex99-1slide19.jpg GRAPHIC 163639
25 ef20030639_ex99-1slide20.jpg GRAPHIC 314996
26 ef20030639_ex99-1slide21.jpg GRAPHIC 246699
27 ef20030639_ex99-1slide22.jpg GRAPHIC 309238
28 ef20030639_ex99-1slide23.jpg GRAPHIC 134137
29 ef20030639_ex99-1slide24.jpg GRAPHIC 213253
30 ef20030639_ex99-1slide25.jpg GRAPHIC 257930
31 ef20030639_ex99-1slide26.jpg GRAPHIC 171425
32 ef20030639_ex99-1slide27.jpg GRAPHIC 432197
33 ef20030639_ex99-1slide28.jpg GRAPHIC 346794
34 ef20030639_ex99-1slide29.jpg GRAPHIC 298482
35 ef20030639_ex99-1slide30.jpg GRAPHIC 145485
36 ef20030639_ex99-1slide31.jpg GRAPHIC 363004
37 ef20030639_ex99-1slide32.jpg GRAPHIC 371949
38 ef20030639_ex99-1slide33.jpg GRAPHIC 385043
39 ef20030639_ex99-1slide34.jpg GRAPHIC 186341
40 ef20030639_ex99-1slide35.jpg GRAPHIC 136600
41 ef20030639_ex99-1slide36.jpg GRAPHIC 322511
42 ef20030639_ex99-1slide37.jpg GRAPHIC 711537
  Complete submission text file 0001140361-24-028944.txt   14974570

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA atai-20240605.xsd EX-101.SCH 3856
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE atai-20240605_lab.xml EX-101.LAB 22690
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atai-20240605_pre.xml EX-101.PRE 16546
55 EXTRACTED XBRL INSTANCE DOCUMENT ef20030639_8k_htm.xml XML 4213
Mailing Address 524 BROADWAY NEW YORK NY 10013
Business Address WALLSTRASSE 16 BERLIN 2M 10179 (617)-699-5876
ATAI Life Sciences N.V. (Filer) CIK: 0001840904 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40493 | Film No.: 241020792
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)